- REPORT SUMMARY
- TABLE OF CONTENTS
-
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously.
Astellas is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
The report details the trend, potential and market size of Micafungin Sodium for Injection market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Micafungin Sodium for Injectionmarket, defines the market attractiveness level of Micafungin Sodium for Injection market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Micafungin Sodium for Injection industry, describes the types of Micafungin Sodium for Injection market, the applications of major players and the market size, and deeply analyzes the current situation of the global Micafungin Sodium for Injection market and the development prospects and opportunities of Micafungin Sodium for Injection industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Micafungin Sodium for Injection market in Chapter 13.
By Player:
Astellas
By Type:
50 mg Single-use Vial
100 mg Single-use Vial
By End-User:
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Micafungin Sodium for Injection Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Micafungin Sodium for Injection Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Micafungin Sodium for Injection Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Micafungin Sodium for Injection Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Micafungin Sodium for Injection Market Analysis and Outlook to 2022
-
7.1 Global Micafungin Sodium for Injection Consumption (2017-2022)
-
7.2 United States Micafungin Sodium for Injection Consumption (2017-2022)
-
7.3 Europe Micafungin Sodium for Injection Consumption (2017-2022)
-
7.4 China Micafungin Sodium for Injection Consumption (2017-2022)
-
7.5 Japan Micafungin Sodium for Injection Consumption (2017-2022)
-
7.6 India Micafungin Sodium for Injection Consumption (2017-2022)
-
7.7 South Korea Micafungin Sodium for Injection Consumption (2017-2022)
8 Region and Country-wise Micafungin Sodium for Injection Market Analysis and Outlook to 2028
-
8.1 Global Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.2 United States Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.3 Europe Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.4 China Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.5 Japan Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.6 India Micafungin Sodium for Injection Consumption Forecast (2022-2028)
-
8.7 South Korea Micafungin Sodium for Injection Consumption Forecast (2022-2028)
9 Global Micafungin Sodium for Injection Market Outlook by Types and Applications to 2022
-
9.1 Global Micafungin Sodium for Injection Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 50 mg Single-use Vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100 mg Single-use Vial Consumption and Growth Rate (2017-2022)
-
9.2 Global Micafungin Sodium for Injection Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Candidemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Respiratory Mycosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Mycosis Consumption and Growth Rate (2017-2022)
10 Global Micafungin Sodium for Injection Market Outlook by Types and Applications to 2028
-
10.1 Global Micafungin Sodium for Injection Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 50 mg Single-use Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 100 mg Single-use Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Micafungin Sodium for Injection Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Candidemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Respiratory Mycosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastrointestinal Mycosis Consumption Forecast and Growth Rate (2022-2028)
11 Global Micafungin Sodium for Injection Import and Export Analysis (Top 5 Countries)
-
11.1 Global Micafungin Sodium for Injection Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Micafungin Sodium for Injection Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Micafungin Sodium for Injection Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Micafungin Sodium for Injection Market Competitive Analysis
-
14.1 Astellas
-
14.1.1 Astellas Company Details
-
14.1.2 Astellas Micafungin Sodium for Injection Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Micafungin Sodium for Injection Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Micafungin Sodium for Injection
-
Figure Micafungin Sodium for Injection Picture
-
Table Global Micafungin Sodium for Injection Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Micafungin Sodium for Injection Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Micafungin Sodium for Injection Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Micafungin Sodium for Injection Consumption by Country (2017-2022)
-
Figure United States Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Table Europe Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Figure China Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Figure Japan Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Figure India Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Figure South Korea Micafungin Sodium for Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Micafungin Sodium for Injection Consumption Forecast by Country (2022-2028)
-
Figure United States Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Micafungin Sodium for Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50 mg Single-use Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 100 mg Single-use Vial Consumption and Growth Rate (2017-2022)
-
Figure Global Candidemia Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Mycosis Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Mycosis Consumption and Growth Rate (2017-2022)
-
Figure Global 50 mg Single-use Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100 mg Single-use Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Candidemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Mycosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Mycosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Micafungin Sodium for Injection Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Micafungin Sodium for Injection Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Micafungin Sodium for Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Micafungin Sodium for Injection Product and Service
-